Yen et al. Taiwanese study of risk of MACE in SSc. No difference in MACE IRR 1.15 (95%CI 0.87–1.52) or stroke IRR 0.89 (95%CI 0.61-1.29), increase in MI IRR 1.76 (95%CI 1.08-2.86) @RheumNow #ACR22 Abstr#1191 https://t.co/3BiTLafGmk https://t.co/IManEvAh47
Links:
The Risk of Major Adverse Cardiovascular Events in Patients with Systemic Scler…
https://acrabstracts.org/abstract/the-risk-of-major-adverse-cardiovascular-even…
13-11-2022
